Human protein immunoglobulin (Sanquin Blood Supply Foundation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman protein immunoglobulin (Sanquin Blood Supply Foundation)
Drug Alias NameNanogamIVIG-L
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesAgammaglobulinemia +[5] 
Global Approved IndicationsImmunologic Deficiency SyndromesPurpura, Thrombocytopenic, Idiopathic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2004/03/01
Country/TerritoryPolandNetherlandsFrance +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanquin Plasma Products BvFinnish Red Cross Blood Transfusion Service
China Registration ClassN/A

Develop Information

Active CompaniesSanquin Plasma Products Bv
Inactive CompaniesProthya Biosolutions Netherlands BV
Active IndicationsImmunologic Deficiency SyndromesPurpura, Thrombocytopenic, Idiopathic
Inactive IndicationsPrimary Immunodeficiency DiseasesAgammaglobulinemiaCardiomyopathies

Other Information

ATC CodeJ06BA02
Related LinksN/A